Sunrise Senior Living, Inc. (NYSE:SRZ) Investor Investigation Over Potential Breaches Of Fiduciary Duties In Connection With The Proposed Takeover By Health Care REIT, Inc.

Investors who purchased shares of Sunrise Senior Living, Inc. (NYSE:SRZ) prior to August 22, 2012, and currently hold any of those NYSE:SRZ shares, you have certain options and you should contact the Shareholders Foundation, Inc.

To have your information reviewed for options and to recieve notifications about this investigation, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.
Company Name(s): 
Sunrise Senior Living
Affected Securities: 
NYSE: SRZ

Aug. 22, 2012 (Shareholders Foundation) -- An investigation on behalf of investors in Sunrise Senior Living, Inc. (NYSE:SRZ) shares was announced concerning whether the offer by Health Care REIT, Inc. to acquire Sunrise Senior Living, Inc. for $14.50 per NYSE:SRZ share and the takeover process are unfair to investors in NYSE:RBN shares.

The investigation by a law firm concerns whether certain officers and directors of Sunrise Senior Living, Inc. breached their fiduciary duties owed to NYSE:SRZ investors in connection with the proposed acquisition.

On August 22, 2012, Sunrise Senior Living, Inc. (NYSE: SRZ) announced that it has entered into a merger agreement under which Health Care REIT, Inc. (NYSE: HCN) will acquire all of the outstanding common stock of Sunrise Senior Living, Inc for $14.50 per share in an all-cash transaction.

Shares of Sunrise Senior Living, Inc. (NYSE:SRZ) jumped from $8.93 per share on Tuesday to $14.26 per share on August 22, 2012.

However, the investigation a law firm concerns whether the proposed transaction is unfair NYSE:SRZ stockholders. Specifically, the investigation focuses on whether the Sunrise Senior Living Board of Directors undertook an adequate sales process, adequately shopped the company before entering into the transaction, maximized shareholder value by negotiating the best price, and acted in the shareholders' best interests in connection with the proposed sale.